Skip to main content
. Author manuscript; available in PMC: 2016 May 5.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):561–565. doi: 10.1097/PAI.0b013e31824e93f2

Table 1.

Case demographics by diagnosis subtype

Diagnosis # cases M:F Patient Age range Avg Age of Paraffin Blocks (yrs)
PCN 21 11:09 43–86 3.05
PBL 10 7:04 40–63 6.7
MZL 10 4:05 48–87 2.66
LPL 7 5:03 51–79 1.5
FL 8 5:03 45–82 2
CLL/SLL 9 2:07 34–78 2
MCL 8 5:03 53–82 2
Normal 10 7:03 42–87 2
DLBCL 1 1:00 63 7
PTLD 1 0:01 4 1
CD138 neg PB 1 1:00 40 1

plasma cell neoplasm (PCN), plasmablastic lymphoma (PB), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), follicular lymphoma (FL), chronic lymphocytic lymphoma/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma (MCL), Diffuse large B cell lymphoma (DLBCL), a CD138 negative plasmablastic lymphoma (CD138 neg PB), and a post-transplant lymphoproliferative disorder with plasmablastic differentiation (PTLD).